Davenport & Co’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$215K Sell
1,022
-140
-12% -$31.1K ﹤0.01% 1322
2026
Q2
$245K Sell
1,162
-76
-6% -$16.3K ﹤0.01% 1262
2026
Q1
$274K Sell
1,238
-427
-26% -$104K ﹤0.01% 1175
2025
Q4
$422K Sell
1,665
-810
-33% -$203K ﹤0.01% 973
2025
Q3
$612K Buy
2,475
+459
+23% +$110K ﹤0.01% 833
2025
Q2
$484K Buy
+2,016
New +$469K ﹤0.01% 885
2025
Q1
– Sell
-1,317
Closed -$271K – 1218
2024
Q4
$271K Buy
1,317
+3
+0.2% +$658 ﹤0.01% 1032
2024
Q3
$319K Sell
1,314
-10
-0.8% -$2.34K ﹤0.01% 956
2024
Q2
$291K Sell
1,324
-61
-4% -$13.3K ﹤0.01% 958
2024
Q1
$311K Hold
1,385
– – ﹤0.01% 933
2023
Q4
$304K Hold
1,385
– – ﹤0.01% 905
2023
Q3
$304K Hold
1,385
– – ﹤0.01% 873
2023
Q2
$312K Sell
1,385
-4
-0.3% -$800 ﹤0.01% 879
2023
Q1
$266K Buy
+1,389
New +$268K ﹤0.01% 900
2022
Q3
– Sell
-1,250
Closed -$258K – 1029
2022
Q2
$258K Buy
1,250
+120
+11% +$27.1K ﹤0.01% 851
2022
Q1
$273K Sell
1,130
-15
-1% -$3.48K ﹤0.01% 900
2021
Q4
$279K Buy
1,145
+146
+15% +$33.4K ﹤0.01% 939
2021
Q3
$204K Buy
+999
New +$214K ﹤0.01% 974

Other funds holding STE

Davenport & Co's STE Position: Q3 2026 in Review

Davenport & Co reduced its Steris (STE) stake by 12% in Q3 2026, selling an estimated $31.1K and leaving 1,022 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Davenport & Co first reported a position in STE in Q3 2021 and has held it in 18 quarters since. The position peaked at $612K in Q3 2025. 819 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • Davenport & Co held 1,022 shares of Steris worth $215K as of Q3 2026.
  • Davenport & Co sold 140 Steris shares in Q3 2026, an estimated $31.1K.
  • Steris made up ﹤0.01% of Davenport & Co's portfolio in Q3 2026, its #1322 holding.
  • Davenport & Co first reported a position in Steris in Q3 2021 and has held it in 18 quarters since.
  • Davenport & Co's Steris position peaked at $612K in Q3 2025.
  • 819 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.